Ashley Y Choi1, Oliver K Jawitz2, Vignesh Raman2, Samantha E Halpern3, John C Haney2, Jacob A Klapper2, Matthew G Hartwig2. 1. School of Medicine, Duke University, Durham, North Carolina. Electronic address: choi.ashley@duke.edu. 2. Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina. 3. School of Medicine, Duke University, Durham, North Carolina.
Abstract
BACKGROUND: Patterns of use of older donor lungs within this previously underused donor population are poorly characterized. This study examined factors associated with the use of older donor lung allografts and factors associated with survival in recipients of these lungs. METHODS: Adult donors in the United Network for Organ Sharing registry who donated 1 or more organs for transplantation between 2006 and 2018 were analyzed and stratified into older (age >55 years) and younger (age ≤55 years) cohorts. Multivariable logistic and Cox regression were used to identify factors associated with transplantation of older donor lungs and factors associated with survival, respectively. RESULTS: Overall, 202,477 donors were included and stratified by age (older, 40,406 [20%]; younger, 162,071 [80%]). Compared with younger donors, older donors had an increased rate of consent for donation not requested by organ procurement organizations (7.5% vs 1.7%). Donor factors significantly associated with decreased lung use included male sex, increasing donor age, black race, Hispanic ethnicity, cigarette use, cocaine use, donation after circulatory death status, and PaO2/FiO2 (P/F ratio) lower than 350. In recipients of older donor lungs, increasing donor age (hazard ratio [HR], 1.03; 95% confidence interval [CI], 1.01, 1.05), recipient age 47 years or older (HR 1.03; 95% CI, 1.02, 1.04), and male sex (HR, 1.19; 95% CI, 1.02, 1.39) portended worse survival. CONCLUSIONS: Barriers in consenting practices, concerns about organ function, and recipient survival prevent the widespread use of aged allografts for lung transplantation. Better understanding of factors associated with worse outcomes of older donors and modification of organ procurement organization consenting practices may increase the use of these higher-risk donor organs.
BACKGROUND: Patterns of use of older donor lungs within this previously underused donor population are poorly characterized. This study examined factors associated with the use of older donor lung allografts and factors associated with survival in recipients of these lungs. METHODS: Adult donors in the United Network for Organ Sharing registry who donated 1 or more organs for transplantation between 2006 and 2018 were analyzed and stratified into older (age >55 years) and younger (age ≤55 years) cohorts. Multivariable logistic and Cox regression were used to identify factors associated with transplantation of older donor lungs and factors associated with survival, respectively. RESULTS: Overall, 202,477 donors were included and stratified by age (older, 40,406 [20%]; younger, 162,071 [80%]). Compared with younger donors, older donors had an increased rate of consent for donation not requested by organ procurement organizations (7.5% vs 1.7%). Donor factors significantly associated with decreased lung use included male sex, increasing donor age, black race, Hispanic ethnicity, cigarette use, cocaine use, donation after circulatory death status, and PaO2/FiO2 (P/F ratio) lower than 350. In recipients of older donor lungs, increasing donor age (hazard ratio [HR], 1.03; 95% confidence interval [CI], 1.01, 1.05), recipient age 47 years or older (HR 1.03; 95% CI, 1.02, 1.04), and male sex (HR, 1.19; 95% CI, 1.02, 1.39) portended worse survival. CONCLUSIONS: Barriers in consenting practices, concerns about organ function, and recipient survival prevent the widespread use of aged allografts for lung transplantation. Better understanding of factors associated with worse outcomes of older donors and modification of organ procurement organization consenting practices may increase the use of these higher-risk donor organs.
Authors: M Valapour; C J Lehr; M A Skeans; J M Smith; K Uccellini; R Lehman; A Robinson; A K Israni; J J Snyder; B L Kasiske Journal: Am J Transplant Date: 2019-02 Impact factor: 8.086
Authors: David J Hall; Eric I Jeng; Jon A Gregg; Andres Pelaez; Amir M Emtiazjoo; Satish Chandrashekaran; Mauricio Pipkin; Thomas M Beaver; Tiago N Machuca Journal: Ann Thorac Surg Date: 2018-11-13 Impact factor: 4.330
Authors: Michael S Mulvihill; Brian C Gulack; Asvin M Ganapathi; Paul J Speicher; Brian R Englum; Sameer A Hirji; Laurie D Snyder; R Duane Davis; Matthew G Hartwig Journal: Clin Transplant Date: 2017-06-01 Impact factor: 2.863
Authors: Jonathan C Yeung; Marcelo Cypel; Thomas K Waddell; Dirk van Raemdonck; Shaf Keshavjee Journal: Thorac Surg Clin Date: 2009-05 Impact factor: 1.750
Authors: Hendrik A van Leiden; Nichon E Jansen; Bernadette J J M Haase-Kromwijk; Andries J Hoitsma Journal: Transplantation Date: 2010-09-27 Impact factor: 4.939
Authors: Gabriel Loor; Gregor Warnecke; Mauricio A Villavicencio; Michael A Smith; Jasleen Kukreja; Abbas Ardehali; Matthew Hartwig; Mani A Daneshmand; Marshall I Hertz; Stephen Huddleston; Axel Haverich; Joren C Madsen; Dirk Van Raemdonck Journal: Lancet Respir Med Date: 2019-08-01 Impact factor: 30.700
Authors: M R Baldwin; E R Peterson; I Easthausen; I Quintanilla; E Colago; J R Sonett; F D'Ovidio; J Costa; J M Diamond; J D Christie; S M Arcasoy; D J Lederer Journal: Am J Transplant Date: 2013-08-26 Impact factor: 8.086
Authors: Qimeng Gao; Isabel F DeLaura; Imran J Anwar; Samuel J Kesseli; Riley Kahan; Nader Abraham; Aravind Asokan; Andrew S Barbas; Matthew G Hartwig Journal: Front Immunol Date: 2022-07-01 Impact factor: 8.786
Authors: Samantha E Halpern; Alec McConnell; Sarah B Peskoe; Vignesh Raman; Oliver K Jawitz; Ashley Y Choi; Megan L Neely; Scott M Palmer; Matthew G Hartwig Journal: Am J Transplant Date: 2020-10-29 Impact factor: 8.086